lucy v. norling
Barts and The London School of Medicine and Dentistry, Queen Mary University of London
London, United Kingdom
Review Editor
Inflammation Pharmacology
Barts and The London School of Medicine and Dentistry, Queen Mary University of London
London, United Kingdom
Review Editor
Inflammation Pharmacology
Qatar Biomedical Research Institute, Hamad bin Khalifa University
Doha, Qatar
Review Editor
Inflammation Pharmacology
Vanderbilt University Medical Center
Nashville, United States
Review Editor
Inflammation Pharmacology
University of Texas Southwestern Medical Center
Dallas, United States
Review Editor
Inflammation Pharmacology
University of North Carolina at Chapel Hill
Chapel Hill, United States
Review Editor
Inflammation Pharmacology
Faculdade de Farmácia, Center for Health Science, Federal University of Rio de Janeiro
Rio de Janeiro, Brazil
Review Editor
Inflammation Pharmacology
University of Studies G. d'Annunzio Chieti and Pescara
Chieti, Italy
Review Editor
Inflammation Pharmacology
University of Zaragoza
Zaragoza, Spain
Review Editor
Inflammation Pharmacology
Karolinska Institutet (KI)
Solna, Sweden
Review Editor
Inflammation Pharmacology
University of Basilicata
Potenza, Italy
Review Editor
Inflammation Pharmacology
University of Fort Hare
Alice, South Africa
Review Editor
Inflammation Pharmacology
University of Ibadan
Ibadan, Nigeria
Review Editor
Inflammation Pharmacology
Faculty of Pharmacy, University of Coimbra
Coimbra, Portugal
Review Editor
Inflammation Pharmacology
Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University
Taipei, Taiwan
Review Editor
Inflammation Pharmacology
Medical College, Yangzhou University
Yangzhou, China
Review Editor
Inflammation Pharmacology
University of Verona
Verona, Italy
Review Editor
Inflammation Pharmacology